EUVIMEDEUVIMED entdecken
Crossref

Enhancing the Dissolution Rate of Dolutegravir Sodium Using Nanosuspension Technology and a 32 Factorial Design

Bing Xie, Yaping Liu, Xiaotong Li, Pei Yang, Wei He

Pharmaceutical Sciences and Drug Design · 2023

DOI: 10.51847/2ucoyf3jpn ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2023. Verfasst von Bing Xie und 4 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dolutegravir sodium is an effective antiretroviral medication used for the treatment of HIV. The drug is classified as BCS class II, indicating its low solubility at the typical gastric pH. The purpose of this research was to identify and optimize the key operational and formulation factors affecting the drug’s properties, using a 32-factorial design. Nanosuspensions were prepared using PVP K30, polyvinyl alcohol, polxammer 407, and polxammer 188. The study focused on polymer concentration as th

Zitieren

APA

Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2023). Enhancing the Dissolution Rate of Dolutegravir Sodium Using Nanosuspension Technology and a 32 Factorial Design. Pharmaceutical Sciences and Drug Design. https://doi.org/10.51847/2ucoyf3jpn

Vancouver

Xie B, Liu Y, Li X, Yang P, He W. Enhancing the Dissolution Rate of Dolutegravir Sodium Using Nanosuspension Technology and a 32 Factorial Design. Pharmaceutical Sciences and Drug Design. 2023. doi:10.51847/2ucoyf3jpn

BibTeX
@article{Xie2023,
  author = {Xie, Bing and Liu, Yaping and Li, Xiaotong and Yang, Pei and He, Wei},
  title = {Enhancing the Dissolution Rate of Dolutegravir Sodium Using Nanosuspension Technology and a 32 Factorial Design},
  journal = {Pharmaceutical Sciences and Drug Design},
  year = {2023},
  doi = {10.51847/2ucoyf3jpn}
}
Kostenlos starten →